September 2021

CuriRx Launches CuriLytics® Platform to Provide CMC Analytical Services to Support Complex Biotherapeutic Development Using High Resolution Mass Spectrometry

WILMINGTON, Mass., Sept. 21, 2021 /PRNewswire/ CuriRx, Inc., a leading contract research, development and manufacturing organization(CRDMO), announced today the launch of their new CuriLytics® platform with High-Resolution […]